European Stroke Journal (ESJ) is the official publication of the European Stroke Organisation (ESO). ESJ is a fully peer-reviewed journal, launched in 2016 covering clinical stroke research from all fields. Published research includes, but is not limited to, clinical trials, epidemiology, primary and secondary prevention, diagnosis, acute and post-acute management, guidelines, translation of experimental findings into clinical practice, rehabilitation, organisation of stroke care, and societal impact.
This journal is a member of the Committee on Publication Ethics (COPE).
Launched in 2016 the European Stroke Journal (ESJ) is the official journal of the European Stroke Organisation (ESO), a professional non-profit organization with over 1,400 individual members, and affiliations to numerous related national and international societies.
ESJ covers clinical stroke research from all fields, including clinical trials, epidemiology, primary and secondary prevention, diagnosis, acute and post-acute management, guidelines, translation of experimental findings into clinical practice, rehabilitation, organisation of stroke care, and societal impact. It is open to authors from all relevant medical and health professions. Article types include review articles, original research, protocols, guidelines, editorials and letters to the Editor.
Through ESJ, authors and researchers have gained a new platform for the rapid and professional publication of peer reviewed scientific material of the highest standards; publication in ESJ is highly competitive. The journal and its editorial team has developed excellent cooperation with sister organisations such as the World Stroke Organisation and the International Journal of Stroke, and the American Heart Organization/American Stroke Association and the journal Stroke.
ESJ is fully peer-reviewed and is a member of the Committee on Publication Ethics (COPE). Issues are published 4 times a year (March, June, September and December) and articles are published OnlineFirst prior to issue publication.
|Professor Foad Abd-Allah MD||Cairo University, Egypt|
|Dr Rufus Akinyemi MBBS, MSc, PhD, MWACP, FMCP||University of Ibadan, Nigeria|
|Professor Ale Algra MD||University Medical Center Utrecht, The Netherlands|
|Professor Grethe Andersen MD, DMSc||Aarhus University Hospital, Denmark|
|Professor Philip Bath BSc MB BS MD FRCPath FRCP FESO FAHA FBHS FBPhS DSc FMedSci||University of Nottingham, UK|
|Professor Oscar R. Benavente MD, FRCPC||University of British Columbia, Canada|
|Professor Eivind Berge PhD||Oslo University Hospital, Norway|
|Professor Michael Brainin MD, PhD, Dr (hons), FESO FAHA||Danube-University Krems, Austria|
|Professor Martin Brown MA, MD, FRCP||University College London, UK|
|Professor Valeria Caso PhD||Perugia, Italy|
|Professor Ángel Chamorro MD PhD||University of Barcelona, Spain|
|Professor Christopher Chen BMBCh (Oxon), MRCP (UK), FRCP (Edin)||National University of Singapore, Singapore|
|Professor Hanne Krarup Christensen MD, PhD, DMSci, FESO||Bispebjerg Hospital, Denmark|
|Professor Charlotte Cordonnier MD, PhD||University of Lille, France|
|Professor László Csiba PhD, D.Sci.HAS||Debrecen University, Hungary|
|Professor Antoni Dávalos MD, PhD||Autonomous University of Barcelona, Spain|
|Professor Stephen Davis AM MD FRCP Edin FRACP FAHMS||University of Melbourne, Australia|
|Professor Jacques De Keyser MD,PhD||Universitair Ziekenhuis Brussel, Belgium|
|Professor Vida Demarin MD, PhD||International Institute for Brain Health, Croatia|
|Professor Martin Dichgans MD||University of Munich, Germany|
|Professor Exuperio Díez Tejedor MD, PhD||Autónoma University of Madrid, Spain|
|Professor Matthias Endres MD||Charite – Universitaetsmedizin Berlin, Germany|
|Professor Franz Fazekas MD||Universitätsklinik für Neurologie, Austria|
|Professor José M. Ferro MD, PhD||University of Lisbon, Portugal|
|Professor Urs Fischer MD MSc||University of Bern, Switzerland|
|Professor Zuzana Gdovinová PhD||PP.J. Šafárik University Košice, Slovakia|
|Professor Alla Guekht MD PhD||Moscow Research and Clinical Center for Neuropsychiatry & Russian National Research Medical University, Russia|
|Professor Werner Hacke MD PhD DSc (hon mult)||UniversitätsKlinikum Heidelberg, Germany|
|Professor Robert Hart MD||Population Health Research Institute & McMaster University , Canada|
|Professor Peter Heuschmann MD, MPH||Julius Maximilian University of Würzburg, Germany|
|Professor Jaap Kappelle MD||University Medical Center Utrecht, Netherlands|
|Professor Peter Kelly MD MS FRCPI FESO||Mater University Hospital & University College Dublin, Ireland|
|Professor Dheeraj Khurana MD, DM||Postgraduate Institute of Medical Education and Research, India|
|Professor Jong S. kim MD, PhD||University of Ulsan, Korea|
|Professor C.J.M. Klijn MD, PhD||Radboudumc, The Netherlands|
|Professor Yoshihiro Kokubo MD, PhD, FACC, FAHA, FESC, FESO, FJSH||National Cerebral and Cardiovascular Center, Japan|
|Dr Janika Kõrv MD, PhD, FESO||University of Tartu, Estonia|
|Professor Kursad Kutluk||University of Dokuz Eylul, Turkey|
|Professor Peter Langhorne PhD||Universty of Glasgow, UK|
|Professor Maarten G. Lansberg MD, PhD||Stanford Stroke Center, USA|
|Professor Kennedy R. Lees MBChB, Bsc (Hons), MD*, FRCP, FRSE, FESO||University of Glasgow, UK|
|Professor Arne Lindgren MD, PhD||Lunds Universitet, Sweden|
|Professor Perttu J. Lindsberg MD PhD||Helsinki University Hospital, Finland|
|Professor Liping Liu||Beijing Tiantan Hospital, Capital Medical University, China|
|Professor Ming Liu MD, PhD||Sichuan University, China|
|Professor Sheila Martins||Hospital de Clinicas de Porto Alegre, Brazil|
|Professor Jean-Louis Mas MD, PhD||Paris Descartes University, France|
|Dr Ayrton Massaro MD, PhD||Hospital Sirio Libanes São Paulo, Brazil|
|Professor Heinrich Mattle MD||University of Bern, Switzerland|
|Dr Dominick J. H. McCabe PhD, FRCPI, FESO||The Adelaide and Meath Hospital, Ireland|
|Professor Atte Meretoja MD, PhD, MSc(StrokeMed), FRACP||Melbourne, Australia|
|Dr Patrik Michel MD||Centre Cérébrovasculaire, Switzerland|
|Professor Robert Mikulik MD, PhD||St. Anne's University Hospital, Czech Republic|
|Professor Carlos Molina MD, PhD||Hospital Universitari Vall d´Hebron, Spain|
|Dr Joan Montaner MD PhD||Virgen del Rocio Hospital, Spain|
|Professor Thierry Moulin PhD||University of Franche-Comte, France|
|Professor Maciej Niewada||Medical University of Warsaw, Poland|
|Assistant Professor George Ntaios MD, MSc, PhD||University of Thessaly Larissa, Greece|
|Dr Yasushi Okada MD, PhD||National Hospital Organization Kyushu Medical Center, Japan|
|Professor Jeyaraj Pandian MD DM FRACP FRCP FESO||Christian Medical College, India|
|Professor Leonardo Pantoni MD PhD||Università degli Studi di Firenze, Italy|
|Professor Alessandro Pezzini MD||Università degli Studi di Brescia, Italy|
|Professor Jukka Putaala MD, PhD, MSc(Stroke)||Helsinki University Hospital, Finland|
|Professor Peter A. Ringleb||University Hospital Heidelberg, Germany|
|Professor Jonathan Rosand MD, MSc||Massachusetts General Hospital, USA|
|Professor Peter Rothwell FMedSci||Oxford, United Kingdom|
|Professor Simona Sacco MD||University of L’Aquila, Italy|
|Emeritus Professor Peter Sandercock DM||University of Edinburgh, UK|
|Dr Else Sandset PhD||Oslo University Hosptial, Norway|
|Professor Christian Stapf MD||Université de Montréal, Canada|
|Professor Thorsten Steiner MME||Heidelberg University Hospital, Germany|
|Professor Daniel Strbian MD, PhD, MSc (Stroke Med),FESO||Helsinki University Central Hospital, Finland|
|Professor Katharina Sunnerhagen MD, PhD||University of Gothenburg, Sweden|
|Professor Turgut Tatlisumak MD, PhD||Sahlgrenska Academy at University of Gothenburg & Sahlgrenska University Hospital, Sweden|
|Professor Vincent Thijs MD PhD||Austin Health & University of Melbourne, Australia|
|Professor Danilo Toni MD, PhD, FESO||University of Rome, Italy|
|Professor Alexander Tsiskaridze||Tbilisi State University, Georgia|
|Dr H. Bart van der Worp MD, PhD||University Medical Center Utrecht, The Netherlands|
|Dr Mervyn Vergouwen MD PhD||University Medical Center Utrecht, The Netherlands|
|Professor Nils Wahlgren MD, PhD||Karolinska University Hospital, Sweden|
|Professor Joanna Wardlaw MB ChB, MD, FRCR, FRCP, FMedSci, FRSE||University of Edinburgh, UK|
|Professor David Werring FRCP PhD FESO||University College London, UK|
|Professor Lawrence Wong MB MD||Chinese University of Hong Kong, China|
- Article types
- Editorial Policies
2.1 Peer review policy
2.6 Declaration of conflicting interests
2.7 Research ethics and patient consent
2.8 Clinical Trials
2.9 Reporting Guidelines
- Publishing Policies
3.1 Publication Ethics
3.2 Contributor's publishing agreement
3.3 Open Access and author archiving
- Preparing your manuscript
4.1 Word processing formats
4.2 Title Page
4.3 Title, keywords and abstracts
4.4 Corresponding author contact details
4.5 Artwork, figures and other graphics
4.6 Supplementary material
4.7 Journal layout
4.8 Reference Style
4.9 English language editing services
- Submitting your manuscript
5.1 How to submit your manuscript
- On acceptance and publication
6.1 SAGE Production
6.2 Access to your published article
6.3 Online First publication
- Further Information
European Stroke Journal is the fully peer-reviewed official journal of the European Stroke Organisation (ESO), a professional non-profit organization with individual members, and affiliations to numerous related national and international societies.
European Stroke Journal covers clinical stroke research from all fields, including clinical trials, epidemiology, primary and secondary prevention, diagnosis, acute and post-acute management, guidelines, translation of experimental findings into clinical practice, rehabilitation, organisation of stroke care, and societal impact. It is open to authors from all relevant medical and health professions. Article types include review articles, original research, protocols, guidelines, editorials and letters to the Editor.
This Journal is a member of the Committee on Publication Ethics.
This Journal recommends that authors follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals formulated by the International Committee of Medical Journal Editors (ICMJE)
There are no fees payable to submit or publish in this journal (except for requested open access publication).
Please read the guidelines below then visit the Journal’s submission site http://mc.manuscriptcentral.com/esj to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.
Only manuscripts of sufficient quality that meet the aims and scope of European Stroke Journal will be reviewed.
As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.
Letter to the Editor
Original research articles, including: randomised controlled trials, other clinical trials, systematic reviews, and meta-analyses
Protocols of randomised controlled trials and other clinical trials
Overviews of a major topics
*Includes references, disclosures, tables and legends
Letters to the Editor Comments arising from recent articles published in the journal are welcomed. Letters are not divided into sections. Letters to the Editor should not include tables, figures or data supplements.
Original Research Articles should include title page, keywords, structured abstract*, introduction, patients and methods, results, discussion (including limitations as appropriate), conclusion, acknowledgements, declarations, references, and up to 6 tables or figures.
*Structured abstracts should include the following headings: Introduction, Patients and methods, Results, Discussion and Conclusion.
Protocols: Protocols should describe scheduled or ongoing studies, and up to 6 tables or figures.
Review Articles should include title page, keywords, structured abstract*, introduction, method, findings, discussion, conclusion, acknowledgements, disclosures, references, and up to 6 tables or figures.
*Structured abstracts should include the following headings:
Purpose, method, findings, discussion and conclusion.
After initial review by the Editor, a decision is made whether to send the manuscript for external peer review. The Editor will select at least two referees and make a recommendation regarding publication based on their feedback. European Stroke Journal adheres to a single-blind peer review process in which the reviewer’s name is routinely withheld from the author unless the reviewer requests a preference for his/her identity to be revealed. The journal aims to have all manuscripts reviewed as rapidly as possible.
The Editor-in-Chief makes the final decision on all manuscripts. The Vice Editor or a Guest Editor may serve as handling editor for manuscripts for which the Editor-in-Chief has a conflict of interests.
As part of the submission process you will be asked to provide the names of peers who should not be called upon to review your manuscript.
Declaration Guidelines for Authors: http://bit.ly/ESJdeclarations
The following statements should be uploaded under the file type ‘Declarations’ for every manuscript submitted. These will be published at the end of every paper accepted for publication.
Please read the Declaration guidelines for authors available here: http://bit.ly/ESJdeclarations carefully before submitting your Declarations document.
1. Conflicting interests (section 2.6)
2. Funding (section 2.5)
3. Informed consent (section 2.7)
4. Ethical approval (section 2.7)
5. Guarantor (section 2.10)
6. Contributorship (section 2.11)
7. Acknowledgements (section 2.4)
Please see the below example of a completed declarations section:
Conflicting interests: MS is an employee of XXX. BF has received grants from XXX.
Funding: This work was supported by the Medical Research Council [grant number XXX]
Informed consent: Written informed consent was obtained from the patient(s) for their anonymized information to be published in this article.
Ethical approval: The ethics committee of XXXX approved this study (REC number: XXXX)
Contributorship: BF and NP researched literature and conceived the study. MS was involved in protocol development, gaining ethical approval, patient recruitment and data analysis. BF wrote the first draft of the manuscript. All authors reviewed and edited the manuscript and approved the final version of the manuscript
Acknowledgements: We would like to thank XXX XXXX for his assistance and guidance in this research.
Please read the following information carefully for additional information regarding these declarations.
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
- Made a substantial contribution to the concept and design, acquisition of data or analysis and interpretation of data,
- Drafted the article or revised it critically for important intellectual content,
- Approved the version to be published.
Authors should meet the conditions of all of the points above. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.
2.4.1 Writing Assistance
Individuals who provided writing assistance, e.g. from a specialist communciations company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance). It is not necessary to disclose use of language polishing services.
Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.
European Stroke Journal requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
It is the policy of European Stroke Journal to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’.
For guidance on conflict of interest statements, please see the ICMJE recommendations here.
Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki.
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.
For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.
Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.
Please also refer to the ICMJE Recommendations for the Protection of Research Participants
All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.
European Stroke Journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed Consolidated Standards of Reporting Trials (CONSORT) flow chart as a cited figure, and a completed CONSORT checklist as a supplementary file. Report of diagnostic accuracy should adhere to the STARD guidelines. Report of observational studies must adhere to the STROBE statement. Systematic reviews and meta-analyses must be reported according to the PRISMA guidelines.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives
The Guarantor is the person willing to take full responsibility for the article, including for the accuracy and appropriateness of the reference list. This will often be the most senior member of the research group and is commonly also the author for correspondence. Please state this person’s name as initials.
For multi-authored papers this statement should outline what each party contributed to the authorship of the paper. Authors should be identified by their initials. An example is shown below.
BF and NP researched literature and conceived the study. MS was involved in protocol development, gaining ethical approval, patient recruitment and data analysis. BF wrote the first draft of the manuscript. All authors reviewed and edited the manuscript and approved the final version of the manuscript.
SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway.
European Stroke Journal and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of articles published in the journal. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked using duplication-checking software. Where an article is found to have plagiarised other work or included third-party copyright material without permission or with insufficient acknowledgement, or where authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article (removing it from the journal); taking up the matter with the head of department or dean of the author’s institution and/or relevant academic bodies or societies; banning the author from publication in the journal or all SAGE journals, or appropriate legal action.
Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive licence agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
European Stroke Journal offers optional open access publishing via the SAGE Choice programme. For more information please visit the SAGE Choice website. For information on funding body compliance, and depositing your article in repositories, please visit SAGE Publishing Policies on our Journal Author Gateway.
Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
Preferred formats for the text and tables of your manuscript are Word DOC, RTF, XLS. LaTeX files are also accepted. The text should be double-spaced throughout and with a minimum of 3cm for left and right hand margins and 5cm at head and foot. Text should be standard 10 or 12 point. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.
The first page of your manuscript should be the Title Page and should include the following information:
- All author names and affiliations
- Corresponding author contact details
- Structured abstract
Please supply a title, short title, a structured abstract and keywords to accompany your article. The title, keywords and abstract are key to ensuring readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your abstract and select your keywords by visiting the SAGE Journal Author Gateway for guidelines on How to Help Readers Find Your Article Online.
4.3.1 Structuring your abstract
Abstracts should be structured and consist of no more than 250 words.
Original research article abstracts should be structured in the following way:
Introduction: a short statement of the purpose of the study, not a long paragraph of background information
Patients (or materials) and methods
Results:please avoid long lists of detailed values, but state the main findings
Discussion: Level of evidence and any weaknesses of the study
Conclusion: please state whether the aims have been met. References should be avoided, but if essential they must be cited in full. Non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself.
Review article abstracts should be structured in the following way:
Purpose: State what the goal of the review was; what questions are being asked
Method: Summarise search and selection strategies, including patient population, study type and design selected, how studies were selected, any quality criteria used
Findings: Give some results (e.g. number of studies and patients included, percent showing some specified outcome)
Discussion: Discussion of findings
Conclusion: This should relate back to your objective; the question should be answered (or the fact that it cannot be answered made clear)
Provide full contact details for the corresponding author including email, mailing address and telephone numbers. Academic affiliations are required for all co-authors. These details should be presented separately to the main text of the article to facilitate anonymous peer review.
For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines. Figures supplied in colour will appear in colour in print and online.
This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. These will be subjected to peer-review alongside the article. For more information please refer to our guidelines on submitting supplementary files, which can be found within our Manuscript Submission Guidelines page.
European Stroke Journal conforms to the SAGE house style. View the SAGE UK House Style guidelines.
European Stroke Journal adheres to the SAGE Vancouver reference style. View the SAGE Vancouver guidelines to ensure your manuscript conforms to this reference style.
Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.
European Stroke Journal is hosted on SAGE Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit http://mc.manuscriptcentral.com/esj to login and submit your article online.
IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Online Help.
Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be sent by PDF to the corresponding author and should be returned promptly.
SAGE provides authors with online access to their final article.
Online First allows final revision articles (completed articles in queue for assignment to an upcoming issue) to be published online prior to their inclusion in a final journal issue which significantly reduces the lead time between submission and publication. For more information please visit our Online First Fact Sheet
Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the European Stroke Journal editorial office as follows:
Senior Publishing Editor, Medicine and Life Sciences